# Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer

> **NCT02030769** · NA · COMPLETED · sponsor: **Xijing Hospital of Digestive Diseases** · enrollment: 1000 (actual)

## Conditions studied

- Esophageal Neoplasms

## Interventions

- **DRUG:** Pronase
- **DRUG:** Control

## Key facts

- **NCT ID:** NCT02030769
- **Lead sponsor:** Xijing Hospital of Digestive Diseases
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2016-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02030769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02030769, "Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02030769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*